Skleroderma hastalarında soğuk stresin sağ ventrikülün fonksiyonu üzerine etkisi
Amaç: Skleroderma (SSc)’da, pulmoner hipertansiyon ve sağ
The effect of cold stress on right ventricular function in patients with systemic sclerosis
Objective: Pulmonary hypertension and right heart failure are poor
___
- 1. Mukerjee D, St George D, Coleiro B, et al. Prevalence and
outcome in systemic sclerosis associated pulmonary arterial
hypertension: application of a registry approach. Ann Rheum
Dis 2003;62:1088-93.
- 2. D’Angelo WA, Fries JF, Masi AT, et al. Pathologic
observations in systemic sclerosis (scleroderma). A study of
fifty-eight autopsy cases and fifty-eight matched controls.
Am J Med 1969;46:428-40.
- 3. Clements PJ, Furst DE. Heart involvement in systemic
sclerosis. Clin Dermatol 1994;12:267-75.
- 4. Gashouta MA, Humbert M, Hassoun PM. Update in systemic
sclerosis-associated pulmonary arterial hypertension.
Presse Med 2014;43(10 Pt 2):e293-304. doi: 10.1016/j.
lpm.2014.06.007
- 5. Steen VD. Clinical manifestations of systemic sclerosis.
Semin Cutan Med Surg 1998;17:48-54.
- 6. Keir GJ, Nair A, Giannarou S, et al. Pulmonary vasospasm
in systemic sclerosis: noninvasive techniques for detection.
Pulm Circ 2015;5:498-505. doi: 10.1086/682221
- 7. Wise RA, Wigley F, Newball HH, et al. The effect of cold
exposure on diffusing capacity in patients with Raynaud’s
phenomenon. Chest 1982;81:695-8.
- 8. Sakamoto K, Houya I, Inoue K, et al. An imbalance in
plasma prostanoids in patients with Raynaud’s phenomenon
and pulmonary vasospasm. Eur Respir J 1999;13:137-44.
- 9. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma
(systemic sclerosis): classification, subsets and pathogenesis.
J Rheumatol 1988;15:202-5.
- 10. Shuck JW, Oetgen WJ, Tesar JT. Pulmonary vascular
response during Raynaud’s phenomenon in progressive
systemic sclerosis. Am J Med 1985;78:221-7.
- 11. Mukerjee D, Yap LB, Ong V, et al. The myth of pulmonary
Raynaud’s phenomenon: the contribution of pulmonary
arterial vasospasm in patients with systemic sclerosis
related pulmonary arterial hypertension. Ann Rheum Dis
2004;63:1627-31. doi: 10.1136/ard.2003.015289
- 12. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations
for cardiac chamber quantification by echocardiography
in adults: an update from the American Society of
Echocardiography and the European Association of
Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging
2015;16:233-70. doi: 10.1093/ehjci/jev014
- 13. Wang YC, Huang CH, Tu YK. Pulmonary Hypertension and
Pulmonary Artery Acceleration Time: A Systematic Review
and Meta-Analysis. J Am Soc Echocardiogr 2018;31:201-10.
e3. doi: 10.1016/j.echo.2017.10.016
- 14. Ferri C, Giuggioli D, Sebastiani M, et al. Heart involvement
and systemic sclerosis. Lupus 2005;14:702-7.
- 15. Agoston G, Gargani L, Miglioranza MH, et al. Left atrial
dysfunction detected by speckle tracking in patients with
systemic sclerosis. Cardiovasc Ultrasound 2014;12:30. doi:
10.1186/1476-7120-12-30
- 16. Ucar Elalmis O, Cicekcioglu H, Karagoz A, et al. Evaluation
of aortic elastic properties in patients with systemic sclerosis.
Turk Kardiyol Dern Ars 2014;42:635-42. doi: 10.5543/
tkda.2014.03162
- 17. Poanta L, Dadu R, Tiboc C, et al. Systolic and diastolic
function in patients with systemic sclerosis. Eur J Intern Med
2009;20:378-82. doi: 10.1016/j.ejim.2008.10.011
- 18. D’Andrea A, Stisi S, Caso P, et al. Associations between
left ventricular myocardial involvement and endothelial
dysfunction in systemic sclerosis: noninvasive assessment in
asymptomatic patients. Echocardiography 2007;24:587-97.
doi: 10.1111/j.1540-8175.2007.00436.x
- 19. Can I, Onat AM, Aytemir K, et al. Detecting subclinical
biventricular impairment in scleroderma patients by use
of pulsed-wave tissue Doppler imaging. Tex Heart Inst J
2009;36:31-7.
- 20. Spethmann S, Rieper K, Riemekasten G, et al.
Echocardiographic follow-up of patients with systemic
sclerosis by 2D speckle tracking echocardiography of the
left ventricle. Cardiovasc Ultrasound 2014;12:13. doi:
10.1186/1476-7120-12-13
- 21. Faludi R, Kolto G, Bartos B, et al. Five-year follow-up
of left ventricular diastolic function in systemic sclerosis
patients: determinants of mortality and disease progression.
Semin Arthritis Rheum 2014;44:220-7. doi: 10.1016/j.
semarthrit.2014.04.001
- 22. Saito M, Wright L, Negishi K, et al. Mechanics and prognostic
value of left and right ventricular dysfunction in patients with
systemic sclerosis. Eur Heart J Cardiovasc Imaging 2017 doi:
10.1093/ehjci/jex147
- 23. Durmus E, Sunbul M, Tigen K, et al. Right ventricular and atrial
functions in systemic sclerosis patients without pulmonary
hypertension. Speckle-tracking echocardiographic study.
Herz 2015;40:709-15. doi: 10.1007/s00059-014-4113-2
100 Yılmaztepe et al.
Effect of cold stress on the right heart in scleroderma Marmara Medical Journal 2018; 31: 94-100
- 24. Huez S, Roufosse F, Vachiery JL, et al. Isolated right
ventricular dysfunction in systemic sclerosis: latent
pulmonary hypertension? Eur Respir J 2007;30:928-36. doi:
10.1183/09031936.00025607
- 25. Lindqvist P, Caidahl K, Neuman-Andersen G, et al.
Disturbed right ventricular diastolic function in patients with
systemic sclerosis: a Doppler tissue imaging study. Chest
2005;128:755-63. doi: 10.1378/chest.128.2.755
- 26. Cannon PJ, Hassar M, Case DB, et al. The relationship of
hypertension and renal failure in scleroderma (progressive
systemic sclerosis) to structural and functional abnormalities
of the renal cortical circulation. Medicine (Baltimore)
1974;53:1-46.
- 27. Alexander EL, Firestein GS, Weiss JL, et al. Reversible coldinduced
abnormalities in myocardial perfusion and function
in systemic sclerosis. Ann Intern Med 1986;105:661-8.
- 28. Gustafsson R, Mannting F, Kazzam E, et al. Cold-induced
reversible myocardial ischaemia in systemic sclerosis.
Lancet 1989;2(8661):475-9.
- 29. Mizuno R, Fujimoto S, Saito Y, et al. Cardiac Raynaud’s
phenomenon induced by cold provocation as a predictor of
long-term left ventricular dysfunction and remodelling in
systemic sclerosis: 7-year follow-up study. Eur J Heart Fail
2010;12:268-75. doi: 10.1093/eurjhf/hfp198
- 30. Quarta S, Galea N, Gigante A, et al. The cardiac magnetic
resonance in the diagnosis of cardiac Raynaud phenomenon
in a patient with systemic sclerosis: case report and review
of literature. Expert Rev Clin Immunol 2016;12:251-5. doi:
10.1586/1744666X.2016.1134320
- 31. Crosswhite P, Sun Z. Inhibition of phosphodiesterase-1
attenuates cold-induced pulmonary hypertension.
Hypertension 2013;61:585-92. doi: 10.1161/
HYPERTENSIONAHA.111.00676
- 32. Fahey PJ, Utell MJ, Condemi JJ, et al. Raynaud’s phenomenon
of the lung. Am J Med 1984;76(2):263-9.
- 33. Barr WG, Fahey PJ. Reduction of pulmonary capillary blood
volume following cold exposure in patients with Raynaud’s
phenomenon. Chest 1988;94:1195-9.
- 34. Lampert E, Charloux A, Lonsdorfer J, et al. The concept of
Raynaud’s phenomenon of the lung revisited. Am J Med
1996;101:468-71.